Literature DB >> 23637020

Conduction disorders after transcatheter aortic valve implantation: a focused review.

Kelly M W McDonnell1, Richard K Shepard.   

Abstract

OPINION STATEMENT: Transcatheter aortic valve implantation (TAVI) is a less invasive approach to aortic valve replacement than traditional open chest surgery. It has been very successful in elderly and sick patients who might have otherwise been turned down for surgery. However, many patients who have the procedure develop conduction disease, including new LBBB or complete heart block, and may need permanent pacing or ongoing follow-up to monitor for worsening conduction problems. Here we discuss the risk for conduction disease with TAVI, identifying which patients may need a pacemaker or long-term rhythm follow-up, and methods to decrease the risk of worsening conduction.

Entities:  

Year:  2013        PMID: 23637020     DOI: 10.1007/s11936-013-0245-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  25 in total

1.  Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.

Authors:  Philippe Généreux; Stuart J Head; Nicolas M Van Mieghem; Susheel Kodali; Ajay J Kirtane; Ke Xu; Craig Smith; Patrick W Serruys; A Pieter Kappetein; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2012-04-11       Impact factor: 24.094

2.  Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.

Authors:  Rodrigo Bagur; Josep Rodés-Cabau; Ronen Gurvitch; Éric Dumont; James L Velianou; Juan Manazzoni; Stefan Toggweiler; Anson Cheung; Jian Ye; Madhu K Natarajan; Kevin R Bainey; Robert DeLarochellière; Daniel Doyle; Philippe Pibarot; Pierre Voisine; Mélanie Côté; François Philippon; John G Webb
Journal:  JACC Cardiovasc Interv       Date:  2012-05       Impact factor: 11.195

3.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

4.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

5.  Two-year outcomes after transcatheter or surgical aortic-valve replacement.

Authors:  Susheel K Kodali; Mathew R Williams; Craig R Smith; Lars G Svensson; John G Webb; Raj R Makkar; Gregory P Fontana; Todd M Dewey; Vinod H Thourani; Augusto D Pichard; Michael Fischbein; Wilson Y Szeto; Scott Lim; Kevin L Greason; Paul S Teirstein; S Chris Malaisrie; Pamela S Douglas; Rebecca T Hahn; Brian Whisenant; Alan Zajarias; Duolao Wang; Jodi J Akin; William N Anderson; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

6.  Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.

Authors:  Raj R Makkar; Gregory P Fontana; Hasan Jilaihawi; Samir Kapadia; Augusto D Pichard; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; John G Webb; Howard C Herrmann; Joseph E Bavaria; Susheel Kodali; David L Brown; Bruce Bowers; Todd M Dewey; Lars G Svensson; Murat Tuzcu; Jeffrey W Moses; Matthew R Williams; Robert J Siegel; Jodi J Akin; William N Anderson; Stuart Pocock; Craig R Smith; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

7.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

8.  Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation.

Authors:  Laurent Roten; Peter Wenaweser; Etienne Delacrétaz; Gerrit Hellige; Stefan Stortecky; Hildegard Tanner; Thomas Pilgrim; Alexander Kadner; Balthasar Eberle; Marcel Zwahlen; Thierry Carrel; Bernhard Meier; Stephan Windecker
Journal:  Am J Cardiol       Date:  2010-11-15       Impact factor: 2.778

9.  Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function.

Authors:  Rainer Hoffmann; Ralf Herpertz; Sara Lotfipour; Ömer Aktug; Kathrin Brehmer; Walter Lehmacher; Rüdiger Autschbach; Nikolaus Marx; Shahram Lotfi
Journal:  JACC Cardiovasc Interv       Date:  2012-12       Impact factor: 11.195

10.  The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.

Authors:  Konstantinos Spargias; Konstantinos Toutouzas; Michael Chrissoheris; Andreas Synetos; Antonis Halapas; Ioannis Paizis; Georgios Latsios; Konstantinos Stathogiannis; Konstantinos Stathogianni; Spyridon Papametzelopoulos; Stavros Zanos; Gregory Pavlides; Achileas Zacharoulis; Aias Antoniades; Christodoulos Stefanadis
Journal:  Hellenic J Cardiol       Date:  2013 Jan-Feb
View more
  1 in total

Review 1.  Update in Heart Rhythm Abnormalities and Indications for Pacemaker After Transcatheter Aortic Valve Implantation.

Authors:  Marina Saadi; Ana Paula Tagliari; Luiz Cláudio Danzmann; Eduardo Bartholomay; Adriano Nunes Kochi; Eduardo Keller Saadi
Journal:  Braz J Cardiovasc Surg       Date:  2018 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.